TP53 and tongue cancer: In another study, Cho et al. found high VEGF expression in 20 out of 33 specimens of resected tongue cancer (60.6%), but no correlation between it and recurrence (P = .33) [72]; the expressions of maspin, an inhibitor of angiogenesis and tumour suppressant [73, 74], and mutant-type p53 were also evaluated but did not correlate with recurrent disease.